Skip to content
Research Article Open access CC BY 4.0

Pharmacopoeial Standards and Specifications for Pharmaceutical Aerosols: In-Process and Finished Products Quality Control Tests

Md. Sahab Uddin, Mahbubul Hossain, Abdullah Al Mamun, Sonia Zaman, Md. Asaduzzaman, Mamunur Rashid

Advances in Research · pp. 1–12 · Published 29 Dec 2015

10.9734/AIR/2016/22442

Abstract

Pharmaceutical aerosol is a pressurized system that depends on the power of a compressed or liquefied gas to expel the contents from the container. Therapeutic performance of pharmaceutical aerosols is affected by various factors such as actuator tube design, orifice diameter, concentration of surfactant in the system, moisture content and deposition of emitted dose, vapor pressure of propellants, spray pattern, efficiency of valve crimping and measurement of particle size aerosols. Unique feature of this dosage form is the presence of propellants, whose properties like flash point, viscosity and density and presence of active ingredients, containers, valves and actuators also modify the aerosol performance. A pharmaceutical aerosol must satisfy certain standards to claim it to be a quality drug. The main standard for the quality of any drug is the intrinsic and extrinsic elements which contribute directly or indirectly to the safety, potency, efficacy, stability, patient acceptability and regulatory compliance of the products. In process quality control (IPQC) tests are performed in order to remove error from every stage in production. After the manufacturing process is complete finished product quality controls (FPQC) test are performed with respect to the specification of the pharmacopoeias with a view to checks that the quality parameters are within the acceptable limits or not. So, the total quality of pharmaceutical aerosols depends on both IPQC and FPQC tests. The objective of this study is to provide various in-process and finished product quality control tests for pharmaceutical aerosols as per pharmacopoeial standards and specifications.

Pharmaceutical aerosols standard specification in-process quality control finished product quality control

Cited by 13

Pharmaceutical Evaluation of the Suspending Properties of Pentadesma butyracea Gum in Biphasic Liquid Preparations of Diffusible and Indiffusible Powders

Mary-Ann Archer, K. Ofori-Kwakye, Raphael Johnson · Advances in pharmacological and pharmaceutical sciences · 2026

AN OVERVIEW OF COPD: ITS ADVANCED THERAPEUTIC MANAGEMENT AND CHALLENGES FOR DRUG RELEASE AT THE TARGETED SITE

S. A, G. Ravi, Tanvi Painginkar · International Journal of Applied Pharmaceutics · 2025

Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements

Sabrina Magramane, Kristina Vlahović, Péter Gordon · Pharmaceuticals · 2023

Quality control and testing evaluation of pharmaceutical aerosols

Ruwaida W. Abdo, N. Saadi, Nour I. Hijazi · Drug Delivery Systems · 2019

Formulation and Characterization of Pulmonary Drug Delivery Systems

Sabrina Magramane, Z. Pápay, Béla Turbucz · Acta pharmaceutica Hungarica · 2019

Aerosols in pharmaceutical product development

P. Deb, Sara Nidal Abed, H. Maher · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

13

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.